United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
Summary
The “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.
The United States In Vitro Diagnostics Market report provides key information and data on -
Scope
United States In Vitro Diagnostics Tests is segmented as follows -
Reasons to Buy
The United States In Vitro Diagnostics Market report helps you to develop -
Summary
The “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.
The United States In Vitro Diagnostics Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
- 2018 company share and distribution share data for In Vitro Diagnostics Market.
- Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States In Vitro Diagnostics Tests is segmented as follows -
- Cardiac Disease
- Clinical Chemistry
- Hematological Disorders
- Hormonal Disorder
- Infectious Disease
- IVD Analyzers and Reagents
- Metabolic Disorder
- Oncology
- Women's Health
Reasons to Buy
The United States In Vitro Diagnostics Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Table of Contents2 Introduction
3 In Vitro Diagnostics Market, United States
4 Cardiac Disease Market, United States
5 Clinical Chemistry Market, United States
6 Hematological Disorders Market, United States
7 Hormonal Disorders Market, United States
8 Infectious Disease Market, United States
9 IVD Analyzers and Reagents Market, United States
10 Metabolic Disorder Market, United States
11 Oncology Market, United States
12 Women's Health Market, United States
13 Overview of Key Companies in United States, In Vitro Diagnostics Market
14 In Vitro Diagnostics Market Pipeline Products
15 Financial Deals Landscape
16 Recent Developments
17 Appendix
List of Tables
Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2015-2025
Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2018
Table 3: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025
Table 6: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2015-2020
Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2021-2025
Table 8: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2018
Table 9: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Cardiac Disease Market, United States, Volume (Units), 2015-2020
Table 14: Cardiac Disease Market, United States, Volume (Units), 2021-2025
Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2015-2020
Table 16: Cardiac Marker Tests Market, United States, Volume (Units), 2021-2025
Table 17: Cardiac Disease Market, United States, Average Price ($), 2015-2020
Table 18: Cardiac Disease Market, United States, Average Price ($), 2021-2025
Table 19: Cardiac Disease Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018
Table 20: Cardiac Disease Market, United States, Company Share by Revenue ($m), USD Constant, 2018
Table 21: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 22: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 23: Substrates Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 24: Substrates Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 25: Clinical Chemistry Market, United States, Volume (Units), 2015-2020
Table 26: Clinical Chemistry Market, United States, Volume (Units), 2021-2025
List of Figures
Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2018
Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2018
Figure 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025
Figure 6: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2015-2025
Figure 7: In Vitro Diagnostics Market, United States, Company Share (%) 2018
Figure 8: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 9: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 10: Cardiac Disease Market, United States, Volume (Units), 2015-2025
Figure 11: Cardiac Marker Tests Market, United States, Volume (Units), 2015-2025
Figure 12: Cardiac Disease Market, United States, Company Share (%) 2018
Figure 13: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 14: Substrates Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 15: Clinical Chemistry Market, United States, Volume (Units), 2015-2025
Figure 16: Substrates Market, United States, Volume (Units), 2015-2025
Figure 17: Clinical Chemistry Market, United States, Company Share (%) 2018
Figure 18: Hematological Disorders Market, United States, Revenue Mix ($m), 2018
Figure 19: Hematological Disorders Market, United States, Segment Contribution (%), 2018
Figure 20: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 21: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 22: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 23: Hematological Disorders Market, United States, Volume (Units), 2015-2025
Figure 24: Hematology Tests Market, United States, Volume (Units), 2015-2025
Figure 25: Hemostasis Tests Market, United States, Volume (Units), 2015-2025
Figure 26: Hematological Disorders Market, United States, Company Share (%) 2018
Figure 27: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 28: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 29: Hormonal Disorders Market, United States, Volume (Units), 2015-2025
Figure 30: Thyroid Function Tests Market, United States, Volume (Units), 2015-2025
Figure 31: Hormonal Disorders Market, United States, Company Share (%) 2018
Figure 32: Infectious Disease Market, United States, Revenue Mix ($m), 2018
Figure 33: Infectious Disease Market, United States, Segment Contribution (%), 2018
Figure 34: Infectious Disease Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 35: Chlamydia Trachomatis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 36: Clostridium difficile Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 37: Cytomegalovirus (CMV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 38: Hepatitis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 40: Human Papilloma Virus (HPV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 42: Mycobacterium Tuberculosis Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 43: Neisseria Gonorrhoeae Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 44: Treponema pallidum Tests Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 45: Infectious Disease Market, United States, Volume (Units), 2015-2025
Figure 46: Chlamydia Trachomatis Tests Market, United States, Volume (Units), 2015-2025
Figure 47: Clostridium difficile Tests Market, United States, Volume (Units), 2015-2025
Figure 48: Cytomegalovirus (CMV) Tests Market, United States, Volume (Units), 2015-2025
Figure 49: Hepatitis Tests Market, United States, Volume (Units), 2015-2025
Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, United States, Volume (Units), 2015-2025
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Siemens Healthineers AG
